How Safe and Effective are New Drugs for Stroke Prevention?
For decades, warfarin was the only oral blood thinner available to reduce the risk of stroke for patients with atrial fibrillation. Warfarin use is cumbersome because it requires ongoing blood tests to monitor the effect and has numerous drug and food interactions. Now, a number of non-vitamin K antagonist oral anticoagulant (NOAC) drugs are available for patients with atrial fibrillation and claim to revolutionize the care for patients with atrial fibrillation.
“We have strong data from large randomized clinical trials which demonstrate that the new medications are at least as good as warfarin in preventing stroke in atrial fibrillation,” says Dr. Noseworthy. “However, the question many clinicals and patients are interested in is how do these medications compare to each other?”
Click here to read more.
Spine World Summit
Jan. 26, 2018 - Jan. 27, 2018; Hong Kong
6th Ottawa Neurosurgery Review Course
Feb. 3, 2018 - Feb. 10, 2018; Ottawa, ON Canada
Winter Clinics for Cranial and Spinal Surgery
Feb. 25, 2018 - Mar. 1, 2018; Snowmass Village, Colo.
69th Southern Neurosurgical Society Annual Meeting
Feb. 28, 2018 - Mar. 3, 2018; San Juan, PR
Second International Brain Mapping Course
April 26-27, 2018; New Orleans